NULOJIX 250 mg/1
BELATACEPT · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · E.R. Squibb & Sons, L.L.C.
NULOJIX is a injection, powder, lyophilized, for solution containing belatacept at 250 mg/1, taken intravenous. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- NULOJIX
- Generic Name
- BELATACEPT
- NDC Code (Product)
0003-0371- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 250 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125288
- Drug Class
- Selective T Cell Costimulation Blocker [EPC]
- Marketing Start
- 06/15/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is NULOJIX used for?
NULOJIX contains BELATACEPT. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is NULOJIX a controlled substance?
NULOJIX is not classified as a controlled substance by the DEA.
What is the generic name for NULOJIX?
The generic name for NULOJIX is BELATACEPT. There are no other listed brand versions of BELATACEPT.
What is the NDC code for NULOJIX 250 mg/1?
The NDC (National Drug Code) for NULOJIX 250 mg/1 is 0003-0371, listed by E.R. Squibb & Sons, L.L.C..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)